These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16871815)

  • 1. An evaluation of a Lyme disease prevention program in a working population.
    Nolan K; Mauer MP
    Am J Health Promot; 2006; 20(6):379-82. PubMed ID: 16871815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lyme disease vaccine--a public health perspective.
    Shen AK; Mead PS; Beard CB
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s247-52. PubMed ID: 21217171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for primary and secondary prevention of Lyme disease.
    Corapi KM; White MI; Phillips CB; Daltroy LH; Shadick NA; Liang MH
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):20-5. PubMed ID: 17203005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lyme vaccine: a cautionary tale.
    Nigrovic LE; Thompson KM
    Epidemiol Infect; 2007 Jan; 135(1):1-8. PubMed ID: 16893489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States.
    Hook SA; Hansen AP; Niesobecki SA; Meek JI; Bjork JKH; Kough EM; Peterson MS; Schiffman EK; Rutz HJ; Rowe AJ; White JL; Peel JL; Biggerstaff BJ; Hinckley AF
    Vaccine; 2022 Jan; 40(2):298-305. PubMed ID: 34895785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the Lyme disease vaccine.
    Hsia EC; Chung JB; Schwartz JS; Albert DA
    Arthritis Rheum; 2002 Jun; 46(6):1651-60. PubMed ID: 12115198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyme disease vaccine as a strategy for prevention.
    Sood SK
    J Pediatr; 2001 Apr; 138(4):609-10. PubMed ID: 11295736
    [No Abstract]   [Full Text] [Related]  

  • 8. Lyme disease knowledge, attitudes, and behaviors--Connecticut, 1992.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jul; 41(28):505-7. PubMed ID: 1630426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine against Lyme disease.
    Volkman D
    Health News; 1999 Feb; 5(2):1-2. PubMed ID: 9972105
    [No Abstract]   [Full Text] [Related]  

  • 10. Preview: Lyme disease vaccines.
    Donnelly EF
    Med Health R I; 1998 Nov; 81(11):373-5. PubMed ID: 15580796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyme risk for immigrants to the United States: the role of an educational tool.
    Jenks NP; Trapasso J
    J Travel Med; 2005; 12(3):157-60. PubMed ID: 15996445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyme disease: Part II. Management and prevention.
    Bhate C; Schwartz RA
    J Am Acad Dermatol; 2011 Apr; 64(4):639-53; quiz 654, 653. PubMed ID: 21414494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevention of Lyme disease with vaccine.
    Poland GA; Jacobson RM
    Vaccine; 2001 Mar; 19(17-19):2303-8. PubMed ID: 11257352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. By the way, doctor. I was vaccinated against Lyme disease in 2000. Do I still need to be careful about tick bites?
    Robb-Nicholson C
    Harv Womens Health Watch; 2006 Aug; 13(12):8. PubMed ID: 17120334
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
    Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
    N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and Knowledge Needs about Lyme Disease among Occupational and Recreational Users of the Outdoors.
    St Pierre SE; Gould ON; Lloyd V
    Int J Environ Res Public Health; 2020 Jan; 17(1):. PubMed ID: 31948017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding consumer and clinician perceptions of a potential Lyme disease vaccine.
    Devchand R; Koehler L; Hook S; Marx GE; Hooks H; Schwartz A; Hinckley A
    Health Educ Res; 2022 Jan; 36(5):494-504. PubMed ID: 34529775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.
    Schoen RT; Sikand VK; Caldwell MC; Van Hoecke C; Gillet M; Buscarino C; Parenti DL
    Clin Ther; 2000 Mar; 22(3):315-25. PubMed ID: 10963286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyme vaccine: issues and controversies.
    Rahn DW
    Infect Dis Clin North Am; 2001 Mar; 15(1):171-87. PubMed ID: 11301814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyme disease and the Lyme disease vaccines.
    Sigal LH
    Bull Rheum Dis; 1999 Apr; 48(4):1-4. PubMed ID: 10418202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.